Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Deferred Osteoporosis Treatment After Kidney Transplantation
jRCT1041250187Recruiting
- Start
- Feb 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of denosumab and romosozumab in osteoporosis (2 arms). Primary endpoint: Percent change in lumbar spine bone mineral density. Started Feb 2026; status: recruiting.
02
Drugs
denosumabromosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on jRCT1041250187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041250187.